Pharmaceuticals

Psychedelic Drugs Market Future Trends Influencing Growth Through 2030

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Psychedelic Drugs Market Projected To Reach By 2030?

The market for psychedelic drugs has experienced rapid expansion in recent years. Its valuation is projected to increase from $6.33 billion in 2025 to $7.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.4%. This historical growth is primarily attributable to several key factors: a significant unmet need in depression treatment, initial academic investigations into psychedelics, instances of their use in underground and compassionate contexts, the constrained effectiveness of standard antidepressants, and a heightened awareness of mental health issues.

The market for psychedelic drugs is projected to experience substantial expansion in the coming years, forecast to reach $13.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. This projected growth is driven by factors such as regulatory approvals permitting medical applications, increasing acceptance among psychiatrists, a broadening pipeline of indications, enhanced data demonstrating positive patient outcomes, and strategic alliances formed between biotechnology firms and healthcare providers. Key trends anticipated during this period encompass the proliferation of psychedelic-assisted therapy initiatives, an increase in clinical trials targeting mental health conditions, greater receptiveness towards alternative psychiatric treatments, clarification of regulatory frameworks for controlled substances, and an uptick in investments from venture capital and pharmaceutical companies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Which Primary Drivers Are Impacting The Psychedelic Drugs Market Growth?

A rise in mental illness cases is anticipated to drive the expansion of the psychedelic drugs market moving ahead. These conditions are defined as health issues characterized by shifts in emotion, thought, or conduct, encompassing disorders like distress and post-traumatic stress disorder. Psychedelic drugs serve in the treatment of depression and post-traumatic stress disorder, with consistent application leading to a reduction in mental illnesses. To illustrate, data from November 2023 from the National Health Service, a UK government department, indicated that in 2023, roughly one in five persons aged 8 to 25 years were estimated to experience a probable mental disorder. This breakdown showed 20.3% among 8 to 16-year-olds, 23.3% for 17 to 19-year-olds, and 21.7% for 20 to 25-year-olds. Consequently, the growing incidence of mental illnesses is a significant factor propelling the expansion of the psychedelic drugs market.

What Are The Main Segments Within The Psychedelic Drugs Market Segment Structure?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Trends Are Influencing The Evolution Of The Psychedelic Drugs Market?

Major companies within the psychedelic drugs market are concentrating on developing innovative solutions, such as pharmaceutical-grade psilocybin formulations, to enhance therapeutic efficacy, ensure safety, and broaden treatment options for mental health disorders. Pharmaceutical-grade psilocybin formulation refers to psilocybin that is produced and standardized to a pharmaceutical quality, ensuring consistent purity, potency, and safety for therapeutic applications. For instance, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, launched its natural psilocybin capsules in Australia for the treatment of TRD. Through this launch, Optimi Health aims to provide a clinically supported treatment option for patients, expand its presence in the Australian mental health market, and accelerate the adoption of psychedelic-assisted therapies.

Who Are The Companies Participating In The Psychedelic Drugs Market?

Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Get The Full Psychedelic Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Region Holds The Highest Market Share In The Psychedelic Drugs Market?

North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Psychedelic Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2026, By The Business Research Company

Psychedelic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Neurological Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795